Skip to content

Healozone Study to Evaluate the Safety and Efficacy of the Use of Ozone for Management of Dental Caries

A Multi-Center Study to Evaluate the Safety and Efficacy of the Use of Ozone for the Management of Fissure Caries

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00495495
Enrollment
394
Registered
2007-07-03
Start date
2007-02-28
Completion date
2009-12-31
Last updated
2015-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Brief summary

Caries means demineralization with the formation of cavities and pulp symptoms and necrosis as an end result. The acids in the mouth are mainly produced by oral bacteria like Streptococcus mutans from bacterial biofilms adhering to the tooth. Ozone has been shown to have a very strong bactericidal effect on bacteria causing dental caries. Baysan et al reported that there was a statistically significant reduction of streptococci in root caries lesions and saliva samples after ozone application. The positive clinical effect of ozone with respect to arresting caries progression and the remineralization of caries has been shown in vitro and in vivo. In an in vivo study, Baysan and Lynch found that the application of ozone resulted in a significant reduction of bacterial contamination as well as a reduction in size and severity of root caries lesions. In a subsequent study, Baysan and Lynch reported that the severity of root caries lesions was significantly reduced after ozone application as measured by electrical conductance and laser fluorescence. In several studies, the caries reducing effect of ozone was measured with biochemical methods in root surface caries lesions, the biofilm and saliva after ozone application. See Citation section for references. The objectives of this multi-center clinical study were to determine: (1) the effectiveness of the HealOzone in stopping the progression of fissure caries; and (2) the oral soft tissue safety of the ozone system.

Detailed description

The proposed study was designed as a twelve-month, multi-center, double-blind, randomized controlled clinical study involving 394 subjects with 788 lesions. There were three sites participating in this trial: Indiana University School of Dentistry (lead site), Tufts University School of Dental Medicine, and SUNY School of Dental Medicine. Each site submitted a version of the protocol to their respective Institutional Review Board (IRB) that incorporated the specific institutional and state guidelines and regulations applicable to that site. The two treatment regimens were: (a) placebo treatment and (b) experimental ozone treatment. Selected subjects had to have at least two teeth with similar stages of early active fissure caries. The selection of the study teeth was determined by a review of the visual examination, including the ICDAS severity score and the caries lesion activity score, conducted at the screening visit, in conjunction with the bitewing radiographs. The decision whether a tooth was to be treated with ozone or receive placebo treatment was made randomly. All clinical personnel involved in the clinical examinations and treatment application were trained at the primary site prior to the initiation of the trial both in the use of the device, and in how to identify the signs and symptoms of ozone toxicity and in how to provide the appropriate medical response should any of these signs or symptoms be observed. All qualified subjects received the following: 1. Professional dental cleaning and scaling at the Screening Visit (or separate visit prior to baseline visit and after completing the study at 12 months. 2. Diagnostic procedures: 1. Clinical visual examination (utilizing the International Caries Detection and Assessment System \[ICDAS\] severity scoring) 2. Clinical visual/tactile assessment of caries lesion activity 3. Bitewing x-rays 4. Laser fluorescence measurement (utilizing the DIAGNOdent, KaVo) 3. Treatment Regimen: Using a split-mouth design, the assigned investigational treatment regimen was administered on the two selected study teeth at the baseline, and at the three-, six- and nine-month appointments. After three, six, nine and twelve months, the diagnostic procedures were repeated with the exception of bitewing x-rays, which were only repeated at the twelve-month exam (unless the examining dentist determined that x-rays also were needed at the six- or nine-month visit to confirm whether dentinal caries were present). In addition, optional digital photographs were taken at the Boston site of selected study teeth to document clinical changes over the study period. If a selected study tooth progressed from an initial caries lesion to a more advanced lesion, which in the judgment of the examining dentist required restorative intervention, the tooth was restored at no cost to the subject and the lesion was recorded as 'progression from baseline' at any remaining examinations. The subject was eligible to remain in the study. Subjects received a thorough dental cleaning and scaling and topical fluoride treatment at the conclusion of the twelve-month examination. The primary efficacy parameter will be the ICDAS severity value. The severity criteria used in the ICDAS diagnostic system are as follows: 0 = Sound tooth surface. 1. = First visual change in enamel. 2. = Distinct visual change in enamel. 3. = Localized enamel breakdown due to caries with no visible dentin. 4. = Underlying dark shadow from dentin, with or without localized enamel breakdown. 5. = Distinct cavity with visible dentin. 6. = Extensive distinct cavity with visible dentin. The secondary efficacy parameters will be measured by: Caries Lesion Activity score: 1. = Inactive - surface of enamel appears whitish, brownish or black. Enamel may be shiny and feels hard and smooth when the tip of the probe is moved gently across the surface. 2. = Active lesion - surface of enamel appears whitish/yellowish opaque with loss of luster. The surface feels rough when the tip of the probe is moved gently across the surface. Radiographic Changes: The occlusal surface of study teeth will be evaluated using the following scale: Lesion presence: yes /no Lesion depth: E1 = outer half of enamel E2 = inner half of enamel D1 = outer third of dentin D2 = middle third of dentin D3 = inner third of dentin or greater/pulpal exposure Laser fluorescence measurement: DIAGNOdent reading using a scale from 00 to 99, with 00 indicating no caries activity and 99 indicating a high level of activity.

Interventions

Ozone treatment applied to randomly selected tooth for a period of 60 seconds at Baseline, Three, Six and Nine-Month visits.

DEVICEPlacebo treatment

Placebo treatment applied to randomly selected tooth for a period of 60 seconds at Baseline, Three-, Six- and Nine-Month visits.

Sponsors

Tufts University School of Dental Medicine
CollaboratorOTHER
State University of New York at Buffalo
CollaboratorOTHER
Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
10 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

To be eligible for study participation, subjects had to: 1\. provide written informed consent, HIPAA authorization and medical history information prior to their participation; 2. be between the ages of 10 and 40 years of age; 3. if female and of childbearing potential, agree to: * a urine pregnancy test, which must be negative; * use one form of medically accepted contraceptive measures which include oral contraceptives, condom, or diaphragm with spermicide, Intra Uterine Device (IUD), Depo-Provera, Norplant during the study and for at least 30 days after the last treatment. (Females who are post menopausal, i.e. amenorrhea for the previous 12 months, or surgically sterile may be included.) 4. be in good general health as evidenced by a review of the medical history; 5. have good oral health; 6. agree to comply with all subjects' responsibilities as stated in the protocol (e.g. attendance at appointments, turning off of cell phone during appointment, etc.); and 7. have two posterior (molar or premolar) teeth with active fissure caries as defined by ICDAS severity score between 1 and 4, a caries lesion activity score of 2, and with radiographic evidence indicating that there is no extension past the dentinal enamel junction. Lesions within the same subject ideally should have the same ICDAS criterion; however, the following deviations will be acceptable - teeth with ICDAS criterion 1 paired with a 2, and a 3 paired with a 4.

Exclusion criteria

Any of the following excluded subjects from participating: 1. a medical condition that requires antibiotic therapy prior to dental work; 2. any medical condition that could be expected to interfere with the subject's safety, such as a pacemaker or similar powered implant; 3. selected study teeth with occlusal restorations, sealants, carious lesions extending into dentin, hypomineralization or fluorosis; 4. generalized severe gingivitis or gross unrestored caries; 5. orthodontic appliances that interfere with access to selected study teeth; 6. pregnant or nursing.

Design outcomes

Primary

MeasureTime frameDescription
ICDAS Severity ValueBaseline and One YearClinically significant changes indicating caries progression are defined as changes in ICDAS severity values from 1 or 2 to a 3 or higher, or from a 3 or 4 to a 5 or higher. The severity criteria are as follows: 0 = Sound tooth surface. 1. = First visual change in enamel. 2. = Distinct visual change in enamel. 3. = Localized enamel breakdown due to caries with no visible dentin. 4. = Underlying dark shadow from dentin, with or without localized enamel breakdown. 5. = Distinct cavity with visible dentin. 6. = Extensive distinct cavity with visible dentin.

Secondary

MeasureTime frameDescription
Change in Caries Lesion ActivityBaseline and one yearChange in caries lesion activity at One Year. All teeth were considered Active at Baseline Caries Lesion Activity score: 1. = Inactive - surface of enamel appears whitish, brownish or black. Enamel may be shiny and feels hard and smooth when the tip of the probe is moved gently across the surface. 2. = Active lesion - surface of enamel appears whitish/yellowish opaque with loss of luster. The surface feels rough when the tip of the probe is moved gently across the surface.
Progression of Radiographic Scores at 12 Monthsone yearClinically significant changes for Bitewing x-rays indicating caries progression would be changes in x-ray criterion for lesion presence from no to yes or for lesion depth to a D1 or higher. The occlusal surface of study teeth will be evaluated using the following scale: Lesion presence: yes /no Lesion depth: E1 = outer half of enamel E2 = inner half of enamel D1 = outer third of dentin D2 = middle third of dentin D3 = inner third of dentin or greater/pulpal exposure
Laser Fluorescence Progression-12 Month (Increase From <=20 to >=30)one yearThe change in DIAGNOdent measurements between baseline and twelve-month visits was used as an additional secondary endpoint. Clinically significant changes for DIAGNOdent indicating caries progression would be an increase in DIAGNOdent reading of 10 or more units or an increase in DIAGNOdent reading from below 20 to above 30 units. DIAGNOdent reading using a scale from 00 to 99, with 00 indicating no caries activity and 99 indicating a high level of activity.
Laser Fluorescence Progression-12 Month (Increase at Least 10)one yearThe change in DIAGNOdent measurements between baseline and twelve-month visits was used as an additional secondary endpoint. Clinically significant changes for DIAGNOdent indicating caries progression would be an increase in DIAGNOdent reading of 10 or more units. DIAGNOdent reading using a scale from 00 to 99, with 00 indicating no caries activity and 99 indicating a high level of activity.

Countries

United States

Participant flow

Participants by arm

ArmCount
Ozone Treatment/Placebo Treatment
Study utilized split-mouth design. Each participant had two teeth selected at the start of the study. Each participant was then randomized to receive Ozone treatment on a randomly selected study tooth for 60 seconds and Placebo treatment on a randomly selected study tooth for 60 seconds.
394
Total394

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProtocol Violation99

Baseline characteristics

CharacteristicOzone Treatment/Placebo Treatment
Age, Categorical
<=18 years
102 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
292 Participants
Age, Continuous22.9 years
STANDARD_DEVIATION 7.2
Region of Enrollment
United States
394 participants
Sex: Female, Male
Female
202 Participants
Sex: Female, Male
Male
192 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 394
serious
Total, serious adverse events
5 / 394

Outcome results

Primary

ICDAS Severity Value

Clinically significant changes indicating caries progression are defined as changes in ICDAS severity values from 1 or 2 to a 3 or higher, or from a 3 or 4 to a 5 or higher. The severity criteria are as follows: 0 = Sound tooth surface. 1. = First visual change in enamel. 2. = Distinct visual change in enamel. 3. = Localized enamel breakdown due to caries with no visible dentin. 4. = Underlying dark shadow from dentin, with or without localized enamel breakdown. 5. = Distinct cavity with visible dentin. 6. = Extensive distinct cavity with visible dentin.

Time frame: Baseline and One Year

Population: The study utilized a split-mouth design. The results posted are for the Per Protocol dataset. Subjects who completed all four treatment/examination visits as well as final examination visit without major protocol violations were included in this dataset.

ArmMeasureGroupValue (NUMBER)
Ozone TreatmentICDAS Severity ValueNumber of Teeth with Caries Progression17 teeth
Ozone TreatmentICDAS Severity ValueNumber of Teeth with No Caries Progression278 teeth
Placebo TreatmentICDAS Severity ValueNumber of Teeth with Caries Progression22 teeth
Placebo TreatmentICDAS Severity ValueNumber of Teeth with No Caries Progression273 teeth
Comparison: Null hypothesis: there is no difference between the HealOzone and Placebo devices in the proportion of teeth with lesion progression after 1 year.~Power calculation: the study was sized to have 90% power to detect a 15% difference between treatments in the percentage of teeth with lesion progression at one year (i.e., assuming 45% for the lesions treated with the Placebo device and 30% for the lesions treated with the HealOzone device) with a sample size of 258 subjects completing the study.p-value: 0.1126McNemar
Secondary

Change in Caries Lesion Activity

Change in caries lesion activity at One Year. All teeth were considered Active at Baseline Caries Lesion Activity score: 1. = Inactive - surface of enamel appears whitish, brownish or black. Enamel may be shiny and feels hard and smooth when the tip of the probe is moved gently across the surface. 2. = Active lesion - surface of enamel appears whitish/yellowish opaque with loss of luster. The surface feels rough when the tip of the probe is moved gently across the surface.

Time frame: Baseline and one year

Population: Analyses were based on per protocol subjects, defined as all randomized subjects with no major protocol violations.~Clinically significant changes for Activity Scores were indicated by a change in caries activity status from active to inactive. It should be noted that all teeth were considered active at baseline.

ArmMeasureGroupValue (NUMBER)
Ozone TreatmentChange in Caries Lesion ActivityNumber of Active Caries lesions189 teeth
Ozone TreatmentChange in Caries Lesion ActivityNumber of Non- Active Caries Lesions106 teeth
Placebo TreatmentChange in Caries Lesion ActivityNumber of Active Caries lesions164 teeth
Placebo TreatmentChange in Caries Lesion ActivityNumber of Non- Active Caries Lesions131 teeth
p-value: 0.9777McNemar
Secondary

Laser Fluorescence Progression-12 Month (Increase at Least 10)

The change in DIAGNOdent measurements between baseline and twelve-month visits was used as an additional secondary endpoint. Clinically significant changes for DIAGNOdent indicating caries progression would be an increase in DIAGNOdent reading of 10 or more units. DIAGNOdent reading using a scale from 00 to 99, with 00 indicating no caries activity and 99 indicating a high level of activity.

Time frame: one year

Population: Analyses were based on per protocol subjects, defined as all randomized subjects with no major protocol violations.

ArmMeasureGroupValue (NUMBER)
Ozone TreatmentLaser Fluorescence Progression-12 Month (Increase at Least 10)Number of Teeth with Progression58 teeth
Ozone TreatmentLaser Fluorescence Progression-12 Month (Increase at Least 10)Number of Teeth with No Progression235 teeth
Placebo TreatmentLaser Fluorescence Progression-12 Month (Increase at Least 10)Number of Teeth with Progression52 teeth
Placebo TreatmentLaser Fluorescence Progression-12 Month (Increase at Least 10)Number of Teeth with No Progression241 teeth
p-value: 0.7666McNemar
Secondary

Laser Fluorescence Progression-12 Month (Increase From <=20 to >=30)

The change in DIAGNOdent measurements between baseline and twelve-month visits was used as an additional secondary endpoint. Clinically significant changes for DIAGNOdent indicating caries progression would be an increase in DIAGNOdent reading of 10 or more units or an increase in DIAGNOdent reading from below 20 to above 30 units. DIAGNOdent reading using a scale from 00 to 99, with 00 indicating no caries activity and 99 indicating a high level of activity.

Time frame: one year

Population: Analyses were based on per protocol subjects, defined as all randomized subjects with no major protocol violations (subjects who completed all four treatment/examination visit at Baseline, 3-, 6-, 9-month as well as Final examination at 12-month.

ArmMeasureGroupValue (NUMBER)
Ozone TreatmentLaser Fluorescence Progression-12 Month (Increase From <=20 to >=30)Number of Teeth with Progression16 teeth
Ozone TreatmentLaser Fluorescence Progression-12 Month (Increase From <=20 to >=30)Number of Teeth with No Progression277 teeth
Placebo TreatmentLaser Fluorescence Progression-12 Month (Increase From <=20 to >=30)Number of Teeth with Progression14 teeth
Placebo TreatmentLaser Fluorescence Progression-12 Month (Increase From <=20 to >=30)Number of Teeth with No Progression279 teeth
p-value: 0.6585McNemar
Secondary

Progression of Radiographic Scores at 12 Months

Clinically significant changes for Bitewing x-rays indicating caries progression would be changes in x-ray criterion for lesion presence from no to yes or for lesion depth to a D1 or higher. The occlusal surface of study teeth will be evaluated using the following scale: Lesion presence: yes /no Lesion depth: E1 = outer half of enamel E2 = inner half of enamel D1 = outer third of dentin D2 = middle third of dentin D3 = inner third of dentin or greater/pulpal exposure

Time frame: one year

Population: Analyses were based on per protocol subjects, defined as all randomized subjects with no major protocol violations (subjects who completed all four treatment/examination visit at Baseline, 3-, 6-, 9-month as well as Final examination at 12-month.

ArmMeasureGroupValue (NUMBER)
Ozone TreatmentProgression of Radiographic Scores at 12 MonthsNumber of Teeth with Progression6 teeth
Ozone TreatmentProgression of Radiographic Scores at 12 MonthsNumber of Teeth with No Progression220 teeth
Placebo TreatmentProgression of Radiographic Scores at 12 MonthsNumber of Teeth with Progression12 teeth
Placebo TreatmentProgression of Radiographic Scores at 12 MonthsNumber of Teeth with No Progression214 teeth
p-value: 0.0416McNemar

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026